De-escalated neoadjuvant nab-paclitaxel combined with pyrotinib and trastuzumab in intrinsic HER2-enriched breast cancer (NJMU-BC01): a multicenter, single-arm, phase 2 trial
在HER2富集型乳腺癌中,新辅助化疗方案降低剂量,联合吡咯替尼和曲妥珠单抗治疗(NJMU-BC01):一项多中心、单臂II期临床试验
期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103376
Pan, Hong; Ren, Yi; Zha, Mengyao; Liu, Mingduo; Liu, Xiaoan; Xie, Hui; Zha, Xiaoming; Zhao, Yi; Chen, Lin; Xia, Tiansong; Liu, Zhao; Tao, Jing; Pan, Hua; Sun, Yue; Li, Wei; Wang, Cong; Ding, Qiang; Wang, Shui; Zhou, Wenbin